Mary Kral to Central Nervous System Stimulants
This is a "connection" page, showing publications Mary Kral has written about Central Nervous System Stimulants.
Connection Strength
0.831
-
Effectiveness and Side Effect Profile of Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder in Youth with Epilepsy. J Child Adolesc Psychopharmacol. 2017 Oct; 27(8):735-740.
Score: 0.489
-
Young Children with Attention-Deficit/Hyperactivity Disorder and/or Disruptive Behavior Disorders Are More Frequently Prescribed Alpha Agonists Than Stimulants. J Child Adolesc Psychopharmacol. 2020 03; 30(2):81-86.
Score: 0.146
-
Not All Generic Concerta Is Created Equal: Comparison of OROS Versus Non-OROS for the Treatment of ADHD. Clin Pediatr (Phila). 2016 Nov; 55(13):1197-1201.
Score: 0.110
-
Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate. J Dev Behav Pediatr. 2012 Apr; 33(3):244-51.
Score: 0.086